Amyloidosis causes in children
Amyloidosis is a rare but serious condition characterized by the abnormal accumulation of amyloid proteins in various tissues and organs. While it is more common among adults, especially the elderly, amyloidosis can also occur in children, posing unique diagnostic and treatment challenges. Understanding the causes of amyloidosis in children is crucial for early detection and management, which can significantly influence outcomes.
In children, amyloidosis is often classified into two main types: hereditary (familial) amyloidosis and acquired amyloidosis. Hereditary amyloidosis results from genetic mutations that lead to the production of abnormal amyloidogenic proteins. These mutations are inherited in an autosomal dominant or recessive manner, depending on the specific gene involved. The most common hereditary form in children is familial amyloid polyneuropathy, which can affect peripheral nerves, the heart, and other organs. In these cases, mutations in genes such as TTR (transthyretin), which encodes a transport protein, cause the protein to misfold and deposit as amyloid.
Acquired amyloidosis in children, though rare, can be associated with chronic inflammatory or infectious conditions. Chronic diseases like juvenile rheumatoid arthritis or familial Mediterranean fever can lead to secondary amyloidosis, known as AA amyloidosis. In this form, the amyloid deposits are derived from serum amyloid A protein, an acute-phase reactant produced in response to persistent inflammation. Over time, continued inflammation causes excess serum amyloid A to misfold and deposit in organs such as the kidneys, spleen, liver, and gastrointestinal tract.
Another cause of amyloidosis in children is primary amyloidosis, which is linked to plasma cell dyscrasias. Although more typical in adults, cases have been reported in pediatric populations. In this form, abnormal plasma cells produce excessive amounts of monoclonal light chains, which form amyloid deposits. These deposits can lead to organ dysfunction, especially affecting the kidneys and heart.
Genetic mutations are the most prominent cause of amyloidosis in pediatric cases, emphasizing the importance of family history and genetic counseling. Some inherited forms are associated with specific syndromes, such as hereditary systemic amyloidosis, which can involve multiple organs from an early age. Early recognition of symptoms, such as unexplained organ enlargement, neuropathy, or heart failure, can prompt further genetic testing and tissue biopsy to confirm amyloid deposition.
In summary, amyloidosis causes in children are diverse, primarily revolving around genetic factors and chronic inflammatory conditions. While genetic mutations are the predominant cause, secondary amyloidosis related to persistent inflammation also contributes. Due to the variety of causes, a multidisciplinary approach involving genetic counseling, laboratory testing, and tissue biopsy is essential for accurate diagnosis and effective management. Early detection can improve quality of life and help prevent irreversible organ damage in affected children.